BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 29558439)

  • 21. Efficient stereoselective synthesis of 2-acetamido-1,2-dideoxyallonojirimycin (DAJNAc) and sp(2)-iminosugar conjugates: Novel hexosaminidase inhibitors with discrimination capabilities between the mature and precursor forms of the enzyme.
    de la Fuente A; Rísquez-Cuadro R; Verdaguer X; García Fernández JM; Nanba E; Higaki K; Ortiz Mellet C; Riera A
    Eur J Med Chem; 2016 Oct; 121():926-938. PubMed ID: 26564401
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glycosyl triazoles as novel insect β-N-acetylhexosaminidase OfHex1 inhibitors: Design, synthesis, molecular docking and MD simulations.
    Dong L; Shen S; Chen W; Lu H; Xu D; Jin S; Yang Q; Zhang J
    Bioorg Med Chem; 2019 Jun; 27(12):2315-2322. PubMed ID: 30528165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective inhibition of β-N-acetylhexosaminidases by thioglycosyl-naphthalimide hybrid molecules.
    Chen W; Shen S; Dong L; Zhang J; Yang Q
    Bioorg Med Chem; 2018 Jan; 26(2):394-400. PubMed ID: 29242020
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design and synthesis of acetamido tri- and tetra-hydroxyazepanes: potent and selective beta-N-acetylhexosaminidase inhibitors.
    Li H; Marcelo F; Bello C; Vogel P; Butters TD; Rauter AP; Zhang Y; Sollogoub M; Blériot Y
    Bioorg Med Chem; 2009 Aug; 17(15):5598-604. PubMed ID: 19592259
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanistic Insights into the Chaperoning of Human Lysosomal-Galactosidase Activity: Highly Functionalized Aminocyclopentanes and
    Weber P; Thonhofer M; Averill S; Davies GJ; Santana AG; Müller P; Nasseri SA; Offen WA; Pabst BM; Paschke E; Schalli M; Torvisco A; Tschernutter M; Tysoe C; Windischhofer W; Withers SG; Wolfsgruber A; Wrodnigg TM; Stütz AE
    Molecules; 2020 Sep; 25(17):. PubMed ID: 32899288
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design, synthesis, and biological evaluation of enantiomeric beta-N-acetylhexosaminidase inhibitors LABNAc and DABNAc as potential agents against Tay-Sachs and Sandhoff disease.
    Rountree JS; Butters TD; Wormald MR; Boomkamp SD; Dwek RA; Asano N; Ikeda K; Evinson EL; Nash RJ; Fleet GW
    ChemMedChem; 2009 Mar; 4(3):378-92. PubMed ID: 19145603
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies on the N-acetyl-beta-D-hexosaminidase B from germinating Lupinus luteus L. seeds. II. Mechanism and inhibition with some 2-acetamido-2-deoxyaldono(1----4)lactones.
    Pócsi I; Kiss L; Zsoldos-Mády V; Pintér I
    Biochim Biophys Acta; 1990 May; 1039(1):119-22. PubMed ID: 2141286
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-throughput screening for human lysosomal beta-N-Acetyl hexosaminidase inhibitors acting as pharmacological chaperones.
    Tropak MB; Blanchard JE; Withers SG; Brown ED; Mahuran D
    Chem Biol; 2007 Feb; 14(2):153-64. PubMed ID: 17317569
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A modeling study for structure features of β-N-acetyl-D-hexosaminidase from Ostrinia furnacalis and its novel inhibitor allosamidin: species selectivity and multi-target characteristics.
    Wang Y; Liu T; Yang Q; Li Z; Qian X
    Chem Biol Drug Des; 2012 Apr; 79(4):572-82. PubMed ID: 22177554
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel potent macrocyclic inhibitors of the hepatitis C virus NS3 protease: use of cyclopentane and cyclopentene P2-motifs.
    Bäck M; Johansson PO; Wångsell F; Thorstensson F; Kvarnström I; Ayesa S; Wähling H; Pelcman M; Jansson K; Lindström S; Wallberg H; Classon B; Rydergård C; Vrang L; Hamelink E; Hallberg A; Rosenquist S; Samuelsson B
    Bioorg Med Chem; 2007 Nov; 15(22):7184-202. PubMed ID: 17845856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. When an inhibitor promotes activity.
    Bouvier M
    Chem Biol; 2007 Mar; 14(3):241-2. PubMed ID: 17379138
    [No Abstract]   [Full Text] [Related]  

  • 32. Identification of a specific inhibitor of nOGA - a caspase-3 cleaved O-GlcNAcase variant during apoptosis.
    Li J; Li Z; Li T; Lin L; Zhang Y; Guo L; Xu Y; Zhao W; Wang P
    Biochemistry (Mosc); 2012 Feb; 77(2):194-200. PubMed ID: 22348480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design and synthesis of 2-acetamidomethyl derivatives of isofagomine as potential inhibitors of human lysosomal beta-hexosaminidases.
    van den Berg RJ; Donker-Koopman W; van Boom JH; Aerts HM; Noort D
    Bioorg Med Chem; 2004 Mar; 12(5):891-902. PubMed ID: 14980601
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A selective inhibitor Gal-PUGNAc of human lysosomal beta-hexosaminidases modulates levels of the ganglioside GM2 in neuroblastoma cells.
    Stubbs KA; Macauley MS; Vocadlo DJ
    Angew Chem Int Ed Engl; 2009; 48(7):1300-3. PubMed ID: 19130519
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lending a helping hand, screening chemical libraries for compounds that enhance beta-hexosaminidase A activity in GM2 gangliosidosis cells.
    Tropak MB; Mahuran D
    FEBS J; 2007 Oct; 274(19):4951-61. PubMed ID: 17894780
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design and synthesis of naphthalimide group-bearing thioglycosides as novel β-N-acetylhexosaminidases inhibitors.
    Shen S; Chen W; Dong L; Yang Q; Lu H; Zhang J
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):445-452. PubMed ID: 29390898
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of PUGNAc and NAG-thiazoline as transition state analogues for human O-GlcNAcase: mechanistic and structural insights into inhibitor selectivity and transition state poise.
    Whitworth GE; Macauley MS; Stubbs KA; Dennis RJ; Taylor EJ; Davies GJ; Greig IR; Vocadlo DJ
    J Am Chem Soc; 2007 Jan; 129(3):635-44. PubMed ID: 17227027
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 2-Acetamido-2-deoxy-d-glucono-1,5-lactone Sulfonylhydrazones: Synthesis and Evaluation as Inhibitors of Human OGA and HexB Enzymes.
    Kiss M; Timári I; Barna T; Mészáros Z; Slámová K; Bojarová P; Křen V; Hayes JM; Somsák L
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35162960
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of GlcNAc-inspired iminocyclitiols as potent and selective N-acetyl-beta-hexosaminidase inhibitors.
    Ho CW; Popat SD; Liu TW; Tsai KC; Ho MJ; Chen WH; Yang AS; Lin CH
    ACS Chem Biol; 2010 May; 5(5):489-97. PubMed ID: 20187655
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TMG-chitotriomycin as a probe for the prediction of substrate specificity of β-N-acetylhexosaminidases.
    Shiota H; Kanzaki H; Hatanaka T; Nitoda T
    Carbohydr Res; 2013 Jun; 375():29-34. PubMed ID: 23685037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.